acted for Oceania Healthcare on its dual listing on the New Zealand and Australian stock exchanges, which was finalised last week.
The Russell McVeagh team was led by senior partner Pip Greenwood
, who said the firm is proud that it led in the first New Zealand stock market listing of the year. Only three companies listed on NZX
main board through IPOs last year. Russell McVeagh also acted on the NZ King Salmon IPO.
Greenwood said that the team worked collaboratively with Oceania Healthcare, the joint lead managers (Deutsche Craigs, First NZ Capital, and Macquarie Capital), PwC, and other advisers of the deal. The listing is further made significant as the Oceania IPO is only the sixth undertaken under the Financial Markets Conduct Act 2013.
"Russell McVeagh has acted for Oceania Healthcare since its inception in 2005, and we are excited to see what the future has in store," Greenwood said.
The dual listing attracted a large volume of high-quality institutional investors both locally and internationally, the firm said. Oceania Healthcare’s IPO raised $200m for the issue of approximately 253.2 million shares at 79c each.
Schemes gain steam in NZ M&A
Top firm releases first social responsibility report